Clinical Trials on Triple-negative Metastatic Breast Cancer
Total 16281 results
-
National University Hospital, SingaporeRecruitingAdvanced Refractory Solid Tumors | Advanced Triple Negative Breast Cancers | Metastatic Triple Negative Breast CancersSingapore
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMetastatic Breast Cancer | Metastatic Triple Negative Breast CancerJapan, Belgium, France, Netherlands
-
Gilead SciencesRecruitingStudy of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors (ASCENT-J02)Advanced Solid Tumor | Metastatic Urothelial Cancer | Metastatic Triple-Negative Breast Cancer | HR+/HER2- Metastatic Breast CancerJapan
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
AkesoRecruitingMetastatic Triple-negative Breast Cancer | Locally Advanced Triple-negative Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingMetastatic Triple-Negative Breast CancerChina
-
University of Texas Southwestern Medical CenterGateway for Cancer Research; Celldex TherapeuticsRecruitingMetastatic Triple Negative Breast CancerUnited States
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMetastatic Triple Negative Breast CancerAustralia
-
Veru Inc.WithdrawnMetastatic Triple Negative Breast Cancer
-
Huihua XiongNot yet recruitingMetastatic Triple-negative Breast CancerChina
-
PharmAbcineMerck Sharp & Dohme LLCRecruitingMetastatic Triple-Negative Breast CancerAustralia
-
Gilead SciencesParexel; IQVIA RDS (Shanghai) Co., Ltd.; Medidata Solutions; Q Squared Solutions...Active, not recruitingMetastatic Triple-negative Breast CancerChina
-
Yale UniversityIovance Biotherapeutics, Inc.CompletedMetastatic Triple Negative Breast CancerUnited States
-
University of Alabama at BirminghamGlaxoSmithKline; AbbVie; Breast Cancer Research Foundation of AlabamaActive, not recruitingMetastatic Triple Negative Breast CancerUnited States
-
Case Comprehensive Cancer CenterCompletedMetastatic Triple Negative Breast CancerUnited States
-
Texas Tech University Health Sciences Center, El...SuspendedMetastatic Triple-Negative Breast CancerUnited States
-
Joseph SparanoRecruitingBreast Neoplasms | Breast Diseases | Metastatic Triple Negative Breast CancerUnited States
-
Wake Forest University Health SciencesMerck Sharp & Dohme LLC; G1 Therapeutics, Inc.RecruitingMetastatic Triple-Negative Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterSynDevRx, Inc.RecruitingBreast Cancer | Metastatic Triple-Negative Breast CancerUnited States
-
AstraZenecaActive, not recruitingMetastatic Triple Negative Breast CancerUnited States, Belgium, Italy, Spain, United Kingdom, Canada, Czechia, Poland, France, Korea, Republic of, Germany, Taiwan, Portugal, Netherlands, Ireland
-
The Methodist Hospital Research InstituteCompletedMetastatic Triple Negative Breast CancerUnited States
-
AHS Cancer Control AlbertaTom Baker Cancer CentreWithdrawnMetastatic Triple Negative Breast CancerCanada
-
Western Regional Medical CenterWithdrawnMetastatic Non-Small Cell Lung Cancer | Metastatic Colon Cancer | Metastatic Triple Negative Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLC; Cedars-Sinai Medical CenterCompletedBreast Cancer | Metastatic Triple NegativeUnited States
-
Fondazione per la Medicina PersonalizzataUniversity of Roma La SapienzaRecruiting
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | TNBC - Triple-Negative Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | Breast Cancer Stage IV | Locally Advanced Breast Cancer | Metastatic Triple-Negative Breast Carcinoma | Locally Advanced Triple-Negative Breast CarcinomaUnited States
-
IFOM ETS - The AIRC Institute of Molecular OncologyAstraZenecaRecruitingTriple Negative Breast Cancer MetastaticItaly
-
Assiut UniversityCompletedEfficacy | Safety Issues | Metastatic Triple Negative Breast CancerEgypt
-
Nippon Kayaku Co., Ltd.CompletedAdvanced Solid Tumors | Metastatic Triple Negative Breast CancerUnited States
-
Sun Yat-sen UniversityTerminatedMetastatic Triple Negative Breast CancerChina
-
Celldex TherapeuticsNo longer availableMetastatic gpNMB Expressing Triple Negative Breast Cancer
-
Celldex TherapeuticsCompletedMetastatic gpNMB Over-expressing Triple Negative Breast CancerUnited States, France, Spain, Italy, Canada, Germany, Australia, Belgium, United Kingdom
-
Merck Sharp & Dohme LLCCompletedMetastatic Triple Negative Breast Cancer
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingCancer | Metastatic | Breast | Triple Negative | Disseminated Tumor CellUnited States
-
Karolinska University HospitalRecruitingMetastatic Triple-Negative Breast CarcinomaSweden
-
OncoTherapy Science, Inc.RecruitingRelapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast CancerUnited States
-
Yuan YuanGateway for Cancer Research; Agenus Inc.RecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast CarcinomaUnited States
-
OHSU Knight Cancer InstituteAstraZeneca; Oregon Health and Science UniversityRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast CarcinomaUnited States
-
Fundacio Clinic BarcelonaSOLTI Breast Cancer Research GroupNot yet recruitingMetastatic Triple-Negative Breast CarcinomaSpain
-
OncoPep, Inc.Not yet recruitingMetastatic Triple-Negative Breast Carcinoma
-
Dompé Farmaceutici S.p.APRA Health SciencesCompletedMetastatic Breast CancerUnited States, Spain, Belgium, Italy, France, Czechia, Poland
-
University of WashingtonAbbVieNo longer availableTriple-Negative Breast Cancer | Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic MutationUnited States
-
National Cancer Institute (NCI)TerminatedBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Hormone Receptor Negative Breast Cancer | HER2+ Breast CancerUnited States
-
HutchmedActive, not recruitingRectal Cancer | Advanced Solid Tumors | Metastatic Breast Cancer | Triple Negative Breast Cancer | Metastatic Colon Cancer | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast CancerUnited States
-
The Netherlands Cancer InstituteHoffmann-La RocheNot yet recruiting
-
University of Milano BicoccaEISAI s.r.l.RecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast CancerItaly
-
Henrik DitzelNational Board of Health, Denmark; CytoVac A/SRecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast CancerDenmark
-
Massachusetts General HospitalMerck Sharp & Dohme LLCActive, not recruitingMetastatic Breast Cancer | Triple Negative Breast CancerUnited States
-
Phoenix Molecular DesignsActive, not recruitingMetastatic Breast Cancer | Triple Negative Breast CancerUnited States